Anavex Life Sciences
AVXL
190 hedge funds and large institutions have $123M invested in Anavex Life Sciences in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 45 reducing their positions, and 29 closing their positions.
211% more call options, than puts
Call options by funds: $7.23M | Put options by funds: $2.33M
67% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 45
34% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 29
4% more funds holding
Funds holding: 183 → 190 (+7)
0.93% more ownership
Funds ownership: 42.22% → 43.15% (+0.93%)
10% less capital invested
Capital invested by funds: $136M → $123M (-$13M)
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$6.9M |
| 2 |
HF
HRT Financial
New York
|
+$2.85M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.63M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.41M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.93M |
Top Sellers
AVXL Hedge Fund Activity: Q1 2026 in Review
190 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2026, worth a combined $123M — down 9.6% from $136M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new AVXL positions and 29 closed out — a net gain of 10 holders — while 75 added to existing stakes and 45 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $6.9M. The largest seller was NWAM LLC, exiting entirely with an estimated $4.37M sold.
- 190 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2026, up from 183 in Q4 2025.
- Funds reported $123M of Anavex Life Sciences stock for Q1 2026, down 9.6% quarter-over-quarter.
- 39 funds opened new Anavex Life Sciences positions in Q1 2026 and 29 closed out, a net change of +10 holders.
- The largest Anavex Life Sciences buyer in Q1 2026 was Two Sigma Investments, an estimated $6.9M added.
- The largest Anavex Life Sciences seller in Q1 2026 was NWAM LLC, an estimated $4.37M sold.
Based on aggregated 13F filings for Q1 2026.